Ballicules › Drugs › Cinacalcet
Pronunciation: sin-a-KAL-set
Mechanism of action: Cinacalcet ballicule
Visual mnemonic: Cinacalcet mascot“Cynical cow sat (on) parathyroid sensor”
What it is Calcium-sensing receptor agonist; secondary hyperparathyroidism in dialysis and parathyroid carcinoma.
Why this one It lowers PTH without raising calcium and phosphate, which vitamin D analogues cannot do.
What limits it Hypocalcemia, which lengthens QT and can cause seizures. Nausea limits titration; it inhibits CYP2D6.
Molecular structure: Cinacalcet
FDA-approved for
hyperparathyroidism (2004)
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Secondary hyperparathyroidism in CKD on dialysis Adults 30 mg QD Titrate to iPTH 150–300 pg/mL 180 mg QD
Hypercalcemia in parathyroid carcinoma / severe primary HPT Adults 30 mg BID Titrate to normalize serum calcium 90 mg TID–QID
Titration Titrate no more frequently than every 2–4 weeks
Renal Undefined
Hepatic Undefined
Instructions Take with food or shortly after a meal Swallow whole — do not chew, crush, or divide iPTH measured no earlier than 12h after most recent dose
Available strengths
Contraindications Serum calcium below the lower limit of normal (do not initiate)
Cautions Hypocalcemia — life-threatening/fatal events reported; can prolong QT, lower seizure threshold, cause hypotension/heart failure/arrhythmia; monitor serum calcium Upper GI bleeding in patients with risk factors Hypotension, worsening heart failure and/or arrhythmias in impaired cardiac function Adynamic bone disease if iPTH <100 pg/mL Not established/indicated in pediatric patients (fatal hypocalcemia reported)
Adverse reactions Nausea and vomiting (≥25%) Diarrhea, myalgia Dizziness, hypertension, asthenia, anorexia Seizures (1.4%)
Pregnancy Limited human data insufficient; animal studies show pup loss/reduced weight with maternal hypocalcemia
Lactation No human data; excreted in rat milk — consider benefits vs. risks
Cost Cinacalcet (SENSIPAR)
What pharmacies pay · NADAC 9/30/26
Strength #/mo generic $/mo CostPlus 30 mg tab 30 qd $12.34 offered 60 mg tab 30 qd $22.97 offered 90 mg tab 30 qd $31.86 offered
Generic entry 2018
Principal risk Hypocalcemia, which lengthens QT
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Open Cinacalcet in the interactive console ↗
Memory aids: interaction avatars
Open Cinacalcet in the interactive console ↗